Currency in USD
Earnings estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 4 | 4 | 4 | 4 |
Avg. Estimate | 1.93 | 2.51 | 10.24 | 11.79 |
Low estimate | 1.78 | 2.29 | 10.14 | 11.45 |
High estimate | 2.13 | 2.77 | 10.31 | 12.09 |
Year ago EPS | 3 | 2.33 | 11.78 | 10.24 |
Revenue estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|
No. of analysts | 4 | 4 | 4 | 4 |
Avg. Estimate | 639.5M | 660.3M | 2.64B | 2.77B |
Low estimate | 624.8M | 642.3M | 2.61B | 2.74B |
High estimate | 656.49M | 678.7M | 2.69B | 2.84B |
Year ago sales | 697.96M | 632.1M | 2.67B | 2.64B |
Sales growth (year/est) | -8.40% | 4.50% | -1.20% | 5.10% |
Earnings history | 29/06/2023 | 29/09/2023 | 30/12/2023 | 30/03/2024 |
---|
Est. EPS | 2.68 | 2.78 | 2.82 | 2.15 |
Actual EPS | 3 | 2.33 | 3.1 | 2.29 |
Difference | 0.32 | -0.45 | 0.28 | 0.14 |
Surprise % | 11.90% | -16.20% | 9.90% | 6.50% |
EPS trend | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|
Current estimate | 1.93 | 2.51 | 10.24 | 11.79 |
7 days ago | 2.29 | 2.59 | 10.61 | 11.75 |
30 days ago | 2.29 | 2.59 | 10.56 | 12 |
60 days ago | 2.49 | 2.75 | 10.7 | 12.15 |
90 days ago | 2.92 | 2.81 | 11.57 | 13.16 |
EPS revisions | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | 1 | N/A | 1 |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | 1 |
Growth estimates | BIO | Industry | Sector(s) | S&P 500 |
---|
Current qtr. | -35.70% | N/A | N/A | N/A |
Next qtr. | 7.70% | N/A | N/A | N/A |
Current year | -13.10% | N/A | N/A | N/A |
Next year | 15.10% | N/A | N/A | N/A |
Next 5 years (per annum) | 17.80% | N/A | N/A | N/A |
Past 5 years (per annum) | 11.12% | N/A | N/A | N/A |